Business Context and Reporting Period
Company: Organogenesis Holdings Inc. (ORGO)
Filing Type: Form 8-K (Current Report)
Date of Report: August 11, 2021
Reporting Period: Event date August 11, 2021
The filing reports a material definitive agreement and the termination of a lease regarding the Company's principal executive offices located at 275 Dan Road, Canton, Massachusetts.
Key Financial Metrics and Transaction Details
This filing details a specific asset acquisition and related debt settlement rather than periodic financial performance metrics (revenue, profit, cash flow). Key transaction figures include:
- Property Purchase Price: $6,000,000 (paid in full at closing).
- Deferred Rent Obligation: $5,062,788.
- Accrued Interest (as of June 30, 2021): $1,053,751.
- Total Debt Settlement: Approximately $6,116,539 (Deferred Rent + Accrued Interest).
- Interest Rate on Remaining Balance: 4.5% simple annual rate (applies to Deferred Rent balance only).
Material Changes and Transaction Structure
On August 11, 2021, the Company purchased the land, building, and improvements at 275 Dan Road from 275 Dan Road SPE, LLC. The Seller is owned by Alan Ades, Dennis Erani, and Glenn Nussdorf, who are significant shareholders and/or Board members of ORGO. Concurrently, the existing lease for the property was terminated.
Repayment Terms for Deferred Rent and Interest:
- Initial Payment: 50% of the total Deferred Rent and Accrued Interest due within 90 days of August 11, 2021.
- Remaining Balance: Paid in five equal installments on January 4, 2022; April 1, 2022; July 1, 2022; October 3, 2022; and January 3, 2023.
- Penalties: No fees or penalties were required for the lease termination beyond the settlement of the deferred rent and interest.
Guidance, Risks, and Related Party Considerations
Related Party Transaction: The transaction involves significant shareholders and Board members (Mr. Ades and Mr. Nussdorf). The agreement was approved by the Audit Committee of the Board of Directors.
Management Commentary: The filing states the transaction was completed pursuant to a Purchase and Sale Agreement. No forward-looking guidance, revenue outlook, or specific risk factors beyond the standard disclosure of the related-party nature of the deal are provided in this specific 8-K.
Key Facts for Investor Verification
- Verify the impact of the $6 million cash outflow on the Company's current liquidity position.
- Confirm the accounting treatment of the $5.06 million deferred rent and $1.05 million accrued interest on the balance sheet.
- Review the full text of the Purchase and Sale Agreement (Exhibit 10.1) for covenants or conditions not summarized in the 8-K.
- Monitor the Company's ability to meet the installment payments due between January 2022 and January 2023.